WESTMINSTER, Colo.--(BUSINESS WIRE)--Allos Therapeutics, Inc. (NASDAQ:ALTH), a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics, today announced that members of the Company’s senior management will participate in a panel discussion starting at 9:00 a.m. Eastern Time at the RBC Capital Markets Health Care Conference on Wednesday, March 3, 2010, at the New York Palace Hotel, New York, NY.
